Cargando…
MALAT1 is involved in type I IFNs-mediated systemic lupus erythematosus by up-regulating OAS2, OAS3, and OASL
Systemic lupus erythematosus (SLE) is an autoimmune disease associated with an aberrant activation of immune cells partly due to the dysfunction of cytokines such as type I interferons (IFNs). Long non-coding RNA MALAT1 has been found to play a pathogenic role in SLE; however, the underlying mechani...
Autores principales: | Gao, Fei, Tan, Yuan, Luo, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184960/ https://www.ncbi.nlm.nih.gov/pubmed/32321151 http://dx.doi.org/10.1590/1414-431X20209292 |
Ejemplares similares
-
Prognostic characterization of OAS1/OAS2/OAS3/OASL in breast cancer
por: Zhang, Yujie, et al.
Publicado: (2020) -
Molecular Mechanisms for the Adaptive Switching Between the OAS/RNase L and OASL/RIG-I Pathways in Birds and Mammals
por: Rong, Enguang, et al.
Publicado: (2018) -
OA14 The role of anifrolumab in treating life threatening systemic lupus erythematosus with severe mucocutaneous involvement
por: Baldwin, Christopher, et al.
Publicado: (2023) -
On the silicon diodes, types OA 200 and OA 202
por: Mulder, P B
Publicado: (1958) -
Vulnerabilities in WINCC OA
por: SEETARAMAN, Savita
Publicado: (2014)